Search our curated selection of resources to find out more about the issues, and to help you in your work.
-
Campaign toolkit – our complete guide
Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent,...
-
Access Granted
A budget advocacy toolkit for improving access to quality and affordable medicines through Global Fund grants.
-
Evergreening patents animation
This animation introduces the concept of ‘evergreening’ patents – strategies used by pharmaceutical companies to extend monopolies and keep prices...
-
Minimum costs to manufacture new treatments for COVID-19
‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Researchers from the University of...
-
COVID-19 drugs can be made for $1 a day
Our short film (1m 47 secs) shows how all potential drugs for the treatment of COVID-19 can be made affordably....
-
The problem with patents
This joint policy brief outlines how patents, and their effect on the cost of HIV treatment, threatens to undermine the HIV response in middle-income countries.
-
Access to Hep C treatment among people who inject drugs
A publication produced by Treatment Action Group (TAG) and Médecins du Monde.
-
Patentability criteria
A research synthesis, produced by Knowledge Portalia.
-
Global Survey on Access to and Quality of HIV Treatment and Care
The 2019 survey focused on barriers to quality HIV care and treatment across 14 low- and middle-income countries covering seven...
-
Activist guide to Hepatitis C diagnostics
Produced by the Treatment Action Group (TAG), the Activist Guide outlines major barriers to accessing testing technologies and services.
-
WHO List of Essential Medicines
The World Health Organization (WHO) updates its essential list of medicines every two years.
-
100% LIFE – 2018 Annual Report
Our partner, 100% LIFE, is the largest patient organization in Ukraine. 100% LIFE employs a range of strategies in order...
-
Join the Fight – Celebrating HIV Activism Then and Now
This ITPC film looks back at how we started, what’s changed and why community activism is still needed now more...
-
MedsPaL – patent information database
MedsPaL provides information on the patent and licensing status of selected HIV, Hepatitis C, TB and other patented essential medicines...
-
The Roadmap – Special Edition Report on Tenofovir Alafenamide Fumarate (TAF)
Make Medicines Affordable partner, the Initiative for Medicines, Access and Knowledge (I-MAK), has produced the Roadmap Special Edition Report on...
-
Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
This intellectual property landscapes tool developed in the MENA region can be used to assess the patent landscape in other countries.
-
EU-Mercosur Bi-regional Association Agreement
The impact of intellectual property on public procurement of medicines in Argentina. This report analyzes the potential impact on access...
-
Estimated costs and prices of essential medicines
Research from the University of Liverpool estimates the costs of production and potential prices for drugs on the WHO’s Essential...
-
Global Summit on IP and Access to Medicines – 2018
All the presentations from our inaugural GSIPA2M in Marrakech, January 2018.
-
Big Pharma Drop the Case!
Argentina and Brazil launch a campaign to demand that pharmaceutical companies drop their case which threatens access to medicines and...
-
The Roadmap – Special Edition Report on Dolutegravir
The Initiative for Medicines, Access and Knowledge (I-MAK), has published a special edition ‘Roadmap report’ on dolutegravir. The report provides...
-
UN Secretary General’s High Level Panel on access to medicines report
Report: Promoting innovation and access to health technologies.
-
How to Conduct Patent Searches for Medicines
This guide helps to identify whether patents related to a pharmaceutical product exist in the country of interest. This is...
-
Glossary of Patent Terminology
This document provides a list of patent terminology published by the OECD in 2006.
-
Public Health Related Trips-Plus Provisions in Bilateral Trade Agreements
This policy guide highlights the adverse effects of bilateral trade agreements on public health and access to medicines in the...
-
World Trade Organization – TRIPS Agreement
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).